Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: A prospective observational study

Critical Care

Volumn 10, Issue 3, 2006, Pages

  Álvarez Lerma, Francisco ^a   Alvarez, Bernabe ^b   Luque, Pilar ^c   Ruiz, Francisco ^d   Dominguez Roldan, Jose Maria ^e   Quintana, Elisabet ^f   Sanz Rodriguez, Cesar ^g   Rello, Jordi ^h   del Castillo, Yolanda ^h   Rodriguez, Alejandro ^h   Benítez, Miguel ⁱ   Ferreras, Jose ^j   Gamacho, Angel ^k   Jimenez, Manuel ^l   Jorda, Ricard ^m   Ucio, Pablo ⁿ   Fernandez, Carlos ^o   Olaechea, Pedro ^p   Alvarez Rocha, Luis ^q   Sierra, Rafael ^r   Blanco, Armando ^s   Ruiz Valverde, Andres ^t   Martinez Coronel, Juan Francisco ^t   Blanco, Javier ^u   López, Javier ^v   Marco, Pilar ^w   Mendieta, Angel ^w   Ugarte, Pablo ^x   Sa, Marcio Borges ^y   more..

^a HOSPITAL DEL MAR   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^d Servicio de Medicina Interna   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^g Medical affairs Merck sharp and Dohme ltd   (Spain)

^h HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

ⁱ HOSPITAL INFANTA CRISTINA   (Spain)

^j HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^k HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^l HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^m HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

ⁿ HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^o Hospital of Leon   (Spain)

^p HOSPITAL DE GALDAKAO   (Spain)

^q HOSPITAL JUAN CANALEJO   (Spain)

^r HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^s HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^t HOSPITAL TORRECÁRDENAS   (Spain)

^u HOSPITAL XERAL CALDE   (Spain)

^v HOSPITAL RAMÓN Y CAJAL   (Spain)

^w HOSPITAL DONOSTIA   (Spain)

^x HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^y HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFOTAXIME; GLYCOPEPTIDE; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; STEROID; TEICOPLANIN; TOBRAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACUTE KIDNEY TUBULE NECROSIS; ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; APACHE; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CRITICALLY ILL PATIENT; DRUG COST; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; GRAM NEGATIVE INFECTION; HOSPITAL COST; HOSPITAL INFECTION; HUMAN; LENGTH OF STAY; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL IDENTIFICATION; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; SEIZURE; SIDE EFFECT; SPAIN; SUPERINFECTION; THROMBOCYTOSIS; COMPARATIVE STUDY; CRITICAL ILLNESS; CROSS INFECTION; EMPIRICAL RESEARCH; INTENSIVE CARE UNIT; MIDDLE AGED; PROSPECTIVE STUDY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CRITICAL ILLNESS; CROSS INFECTION; EMPIRICAL RESEARCH; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PNEUMONIA; PROSPECTIVE STUDIES;

EID: 34247551035     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc4919     Document Type: Article

References (25)

1. Rello J Gallego M Mariscal D Sonora R Valles J The value of routine microbial investigation in ventilator-associated pneumonia Am J Respir Crit Care Med 1997 156 196-200 9230747
2. Iregui M Ward S Sherman G Fraser VJ Kollef MH Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia Chest 2002 122 262-268 10.1378/ chest.122.1.262 12114368
3. Luna CM Vujacich P Niederman MS Vay C Gherardi C Matera J Jolly EC Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia Chest 1997 111 676-685 9118708
4. Álvarez-Lerma F Modification of empiric treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group Intensive Care Med 1996 22 387-394 10.1007/ BF01712153 8796388
5. Kollef MH Sherman G Ward S Fraser VJ Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients Chest 1999 115 462-474 10.1378/chest.115.2.462 10027448
6. Kollef MH Inadequate antimicrobial treatment: An important determinant of outcome for hospitalized patients Clin Infect Dis 2000 31 S131-S138 10.1086/314079 11017862
7. Celis R Torres A Gatell JM Almela M Rodriguez-Roisin R Agusti-Vidal A Nosocomial pneumonia: A multivariate analysis of risk and prognosis Chest 1988 93 318-324 3338299
8. Torres A Aznar R Gatell JM Jimenez P Gonzalez J Ferrer A Celis R Rodriguez-Roisin R Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients Am Rev Respir Dis 1990 142 523-528 2202245
9. Kollef MH Ward S The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia Chest 1998 113 412-420 9498961
10. Mathevon T Souweine B Traore O Aublet B Caillaud D ICU-acquired nosocomial infection: Impact of delay of adequate antibiotic treatment Scand J Infect Dis 2002 34 831-835 10.1080/0036554021000026934 12578154
11. Kollef MH Appropriate empirical antibacterial therapy for nosocomial infections: Getting it right the first time Drugs 2003 63 2157-2168 10.2165/00003495-200363200-00001 14498753
12. Hoffken G Niederman MS Nosocomial pneumonia: The importance of a de-escalation strategy for antibiotic treatment of pneumonia in the ICU Chest 2002 122 2183-2196 10.1378/chest.122.6.2183 12475862
13. Rello J Vidaur L Sandiumenge A Rodriguez A Gualis B Boque C Diaz E De-escalation therapy in ventilator-associated pneumonia Crit Care Med 2004 32 2183-2190 15640629
14. Garner JS Jarvis WR Emori TG Horan TC Hughes JM CDC definitions of nosocomial infections Am J Infect Control 1988 16 128-140 10.1016/ 0196-6553(88)90053-3 2841893
15. Kollef MH Kollef KE Antibiotic utilization and outcomes for patients with clinically suspected ventilator-associated pneumonia and negative quantitative BAL culture results Chest 2005 128 2706-2713 10.1378/ chest.128.4.2706 16236946
16. Carmeli Y Troillet N Eliopoulos GM Samore MH Emergence of antibiotic-resistant Pseudomonas aeruginosa: Comparison of risks associated with different antipseudomonal agents Antimicrob Agents Chemother 1999 43 1379-1382 89282 10348756
17. Lepper PM Grusa E Reichl H Hogel J Trautmann M Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa Antimicrob Agents Chemother 2002 46 2920-2925 127431 12183248 10.1128/ AAC.46.9.2920-2925.2002
18. Aoun M Crokaert F Paesmans M Autier P Klastersky J Imipenem versus targeted therapy in cancer patients Int J Antimicrob Agents 1998 10 263-270 10.1016/S0924-8579(98)00055-7 9916899
19. Namias N Harvill S Ball S McKenney MG Salomone JP Sleeman D Civetta JM Empiric therapy of sepsis in the surgical intensive care unit with broad-spectrum antibiotics for 72 hours does not lead to the emergence of resistant bacteria J Trauma 1998 45 887-891 9820698 10.1097/ 00005373-199811000-00008
20. McGowan JE Jr Antimicrobial resistance in hospital organisms and its relation to antibiotic use Rev Infect Dis 1983 5 1033-1048 6318289
21. Rahal JJ Urban C Horn D Freeman K Segal-Maurer S Maurer J Mariano N Marks S Burns JM Dominick N Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella JAMA 1998 280 1233-1237 9786372 10.1001/jama.280.14.1233
22. Fridkin SK Edwards JR Tenover FC Gaynes RP McGowan JE Jr Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Project. National Nosocomial Infections Surveillance (NNIS) System Hospitals. Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections Clin Infect Dis 2001 33 324-330 10.1086/ 321893 11438897
23. Fridkin SK Edwards JR Courval JM Hill H Tenover FC Lawton R Gaynes RP McGowan JE Jr Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Project. National Nosocomial Infections Surveillance (NNIS) System Hospitals. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units Ann Intern Med 2001 135 173-183
24. Rello J Sa-Borges M Correa H Leal SR Baraibar J Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices Am J Respir Crit Care Med 1999 160 608-613 10430736
25. Álvarez-Lerma F Insausti-Ordenana J Jorda-Marcos R Maravi-Poma E Torres-Marti A Nava J Martinez-Pellus A Palomar M Barcenilla F Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: A prospective randomized multicenter trial Intensive Care Med 2001 27 493-502 10.1007/s001340000846 11355117